Oral Cavity Cancer Clinical Trials

A listing of Oral Cavity Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 84 clinical trials
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers

The purpose of this study is to see if the study drugs, lenvatinib and pembrolizumab, are effective in treating advanced Adenoid Cystic Carcinoma (ACC) or other salivary gland cancers that have come back and/or spread to other parts of the body. Researchers are also doing this study to test the …

pet scan
ct scan
pembrolizumab
cancer
measurable disease
  • 0 views
  • 21 May, 2021
  • 8 locations
Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

The purpose of this study is to To confirm the predictive value of CCND1 for TPF induction in cN2 patients with OSCC

chemotherapy regimen
oral cavity cancer
caries
squamous cell carcinoma of the oral cavity
cavities
  • 19 views
  • 24 Jan, 2021
  • 1 location
GDF15 Based TPF Induction Chemotherapy for OSCC Patients

The purpose of this study is to confirm the predictive value of GDF15 expression for TPF induction in T3/T4cN0M0 patients with OSCC

chemotherapy regimen
oral cavity cancer
caries
squamous cell carcinoma of the oral cavity
cavities
  • 18 views
  • 25 May, 2021
  • 1 location
A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients

To confirm the subgroup result from TPF (docetaxel, cisplatin and 5-fluorouracil ) trial (NCT01542931) that cN2 OSCC patients could benefit from TPF induction chemotherapy compared to the standard treatment.

chemotherapy regimen
oral cavity cancer
mouth cancer
caries
squamous cell carcinoma of the oral cavity
  • 0 views
  • 24 Jan, 2021
  • 1 location
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN

The purpose of this study is to investigate other drugs that may be combined with radiation to treat cancer. The study focuses on determining whether a combination of durvalumab with radiation can both improve cure rate and at the same time have less serious side effects. Throughout this document, this …

carcinoma of the head and neck
durvalumab
carcinoma
neck cancer
primary tumor
  • 19 views
  • 16 May, 2021
  • 2 locations
Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients

Phase 2 pilot study, which evaluates the safety and efficacy of Lutetium-177-PSMA radioligand therapy in advanced salivary gland cancer patients.

pet scan
ct scan
cancer
measurable disease
neutrophil count
  • 0 views
  • 25 Jan, 2021
  • 1 location
LLL Phototherapy in Oral Lesions Resulting From Anti-neoplastic Treatment

Introduction: There are several manifestations in the oral mucosa resulting from antineoplastic treatments by chemo (QT) or radiotherapy (RT). In this study we will collect the variables referring to oral mucositis (OM), radiodermatitis, osteonecrosis of the jaws (ONJ), hyposalivation and xerostomia, dysgeusia, pain, oral candidiasis (opportunistic infection), trismus, quality of …

mucositis
antineoplastic
  • 0 views
  • 26 May, 2021
  • 1 location
Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction

Safety and tolerability of neoadjuvant nivolumab for locally advanced resectable oral cancer, combined with [18F]BMS-986192 / [18F]-FDG PET imaging and immunomonitoring for response prediction

cancer
nivolumab
oral cancer
  • 0 views
  • 25 Jan, 2021
  • 1 location
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors

Phase II, 2-cohort, single arm trial treated with the combination of the following two agents Pembrolizumab (MK3475) 200mg, every three weeks, iv Docetaxel 75mg/m2, every three weeks, iv

carcinoma
measurable disease
angiogenesis inhibitor
metastasis
conjugated bilirubin
  • 107 views
  • 25 Jul, 2021
  • 1 location
The Feasibility of Dexmedetomidine for Awake Fiberoptic Nasal Intubation

The objective of this study is to evaluate the feasibility of dexmedetomidine infusion for oral cancer patients undergoing awake fiberoptic nasal intubation. We hypothesized that a

  • 0 views
  • 07 Nov, 2020
  • 1 location